CZWI

Over the past six months, CZWI's stock price increased by 31.2% over 12 months and 2.66% in the past month, closing at $21.63 on September 22, 2026. On September 2, 2026, the company authorized a new stock buyback program extending into 2027. On July 27, 2026, Q2 2026 earnings of $0.11 per share missed the consensus estimate of $0.41, with total revenue of $11.8 million, leading to a -9.2% daily stock move; the Board also approved a quarterly dividend of $0.105 per share. In August 2026, several analysts downgraded CZWI, including Zacks Research to 'hold,' Wall Street Zen to 'sell,' Citigroup to 'neutral,' Brean Capital to 'neutral,' and Hovde Group to 'market perform,' though Hovde increased its price target. On August 10, 2026, a director and the CEO added shares. Schedule 13G/A filings on August 13-14, 2026, indicated Wellington reported 0% beneficial stake and Manulife Financial disclosed sub-5% ownership. On September 22, 2026, shares briefly moved above their fifty-day moving average before closing at $21.38.